Zobrazeno 1 - 10
of 194
pro vyhledávání: '"A D Nazarov"'
Autor:
K. N. Naumenko, A. R. Nurislamov, K. D. Nazarov, V. S. Fishman, A. A. Popov, I. O. Petruseva, A. N. Evdokimov, O. I. Lavrik
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 28, Iss 7, Pp 688-695 (2024)
DNA repair is a most important cellular process that helps maintain the integrity of the genome and is currently considered by researchers as one of the factors determining the maximum lifespan. The central regulator of the DNA repair process is the
Externí odkaz:
https://doaj.org/article/31fa1c70e5ed4cb698310514b43d6725
Autor:
A. I. Vlasenko, V. D. Nazarov, S. V. Lapin, A. V. Mazing, E. A. Surkova, T. V. Blinova, M. P. Topuzova, T. M. Alekseeva
Publikováno v:
Нервно-мышечные болезни, Vol 14, Iss 3, Pp 72-80 (2024)
In the last decade, pathogenetic methods for the treatment of spinal muscular atrophy 5q have been developed. These include increased expression of the SMN2 gene, correction of SMN2 splicing, or reexpression of the SMN1 gene. Despite the comprehensio
Externí odkaz:
https://doaj.org/article/db80cbb022b4417f910964091c830ea3
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 30, Iss 4, Pp 43-51 (2024)
Introduction. Non-alcoholic fatty liver disease in most cases is closely associated with diseases such as obesity and type 2 diabetes mellitus, however, this dependence is not observed in a number of patients. In this case, hereditary factors, such a
Externí odkaz:
https://doaj.org/article/cd7881b80a8c40409068b499ac4308a1
Publikováno v:
Нервно-мышечные болезни, Vol 13, Iss 3, Pp 33-39 (2023)
Currently, there are three drugs in the world for the pathogenetic therapy of spinal muscular atrophy 5q: nusinersen, risdiplam and onasemnogene abeparvovek. At the same time, it is still unknown to what extent this treatment is able to change the na
Externí odkaz:
https://doaj.org/article/ee4d26c3f9ae4d4dbe026e39f3555988
Publikováno v:
Нервно-мышечные болезни, Vol 12, Iss 3, Pp 36-44 (2022)
Background. Proximal spinal muscular atrophy 5q (5q‑SMA) is one of the most common neuromuscular diseases, which is caused by mutations of the SMN1 gene. Despite the fact that most studies consider SMN1 “deletion” as the most common cause of 5q
Externí odkaz:
https://doaj.org/article/256111deb28f4884aebec07f19989666
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 2, Pp 71-78 (2022)
Introduction. Fine needle aspiration biopsy followed by cytological examination is the gold standard in the diagnosis of thyroid nodules. However, up to one third of cases represent an indeterminate result (Bethesda Thyroid Classification, 2017) III
Externí odkaz:
https://doaj.org/article/bda8c49f56f341f692685f4c13d6a75d
Autor:
K. A. Oganyan, A. A. Musaelyan, M. A. Kotikova, S. V. Lapin, V. D. Nazarov, M. A. Belyaev, A. A. Zakharenko, S. V. Orlov
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 139-146 (2022)
Introduction. The emergence of new markers that determine the choice of therapy for metastatic colorectal cancer (CRC) has led to an increase in overall survival. The optimal treatment tactics now take into account both clinical and molecular-genetic
Externí odkaz:
https://doaj.org/article/c4f8ec53481d489e83a9d5c563598517
Autor:
Andrey D. Nazarov
Publikováno v:
Вопросы ономастики, Vol 19, Iss 1, Pp 30-44 (2022)
The article studies naming conventions among Germanic immigrants who settled in the Eastern Roman empire during the Migration Period. The author uses information from both narrative and epigraphic sources. Many immigrants, finding themselves in a cul
Externí odkaz:
https://doaj.org/article/85470551027e43c59095aad59ec03457
Autor:
A. A. Musaelyan, A. L. Akopov, S. V. Lapin, V. D. Nazarov, D. I. Fillipov, V. L. Emanuel, S. V. Orlov
Publikováno v:
Успехи молекулярной онкологии, Vol 8, Iss 3, Pp 34-43 (2021)
Immune checkpoint inhibitors (ICIs) alone or in combination with chemotherapy have become one of the key approaches in the treatment of patients with advanced non-small cell lung cancer (NSCLC). Evaluation of level of PD-L1 (ligand of the programmed
Externí odkaz:
https://doaj.org/article/62229f8a1c4346e2b9b5224260d6307e
Autor:
V. P. Gomonova, K. L. Raikhelson, E. V. Pazenko, M. K. Prashnova, S. V. Lapin, V. D. Nazarov, D. V. Sidorenko
Publikováno v:
Сеченовский вестник, Vol 0, Iss 0 (2022)
Aim. Тo study cardiometabolic factors and the PNPLA3 I148M (rs738409 C>G) gene polymorphism in association with the compensated advanced chronic liver disease (cACLD) in patients with metabolic dysfunctionassociated steatotic liver disease (MASLD)
Externí odkaz:
https://doaj.org/article/b2db41fd380948928961bcf690d82bed